EcoDrugPlus

Histone Deacetylase 10

Ensembl ID : ENSELUG00000008585
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSELUG00000026940
Gene Symbol: HDAC11
3 Cross references
200 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSELUG00000017897
Gene Symbol: HDAC2
4 Cross references
205 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSELUG00000012563
Gene Symbol: HDAC4
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSELUG00000000960
Gene Symbol: HDAC4
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSELUG00000007133
Gene Symbol: HDAC5
1 Cross references
196 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSELUG00000018637
Gene Symbol: HDAC6
3 Cross references
182 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSELUG00000018039
Gene Symbol: HDAC7
3 Cross references
190 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSELUG00000013857
Gene Symbol: HDAC8
3 Cross references
206 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSELUG00000016589
Gene Symbol: HCN4
3 Cross references
219 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSELUG00000005673
Gene Symbol: HCN4
3 Cross references
211 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSELUG00000020170
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).